A detailed history of Carnegie Lake Advisors LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Carnegie Lake Advisors LLC holds 194,345 shares of RXST stock, worth $1.89 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
194,345
Previous 107,000 81.63%
Holding current value
$1.89 Million
Previous $1.39 Million 25.59%
% of portfolio
0.7%
Previous 0.55%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$6.65 - $13.14 $580,844 - $1.15 Million
87,345 Added 81.63%
194,345 $1.75 Million
Q2 2025

Aug 06, 2025

BUY
$13.0 - $26.12 $1.39 Million - $2.79 Million
107,000 New
107,000 $1.39 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $269M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Carnegie Lake Advisors LLC Portfolio

Follow Carnegie Lake Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Lake Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Lake Advisors LLC with notifications on news.